Clonal diversity of Acinetobacter baumannii from diabetic patients in Saudi Arabian hospitals

Journal of Medical Microbiology

Volumn 63, Issue , 2014, Pages 1460-1466

  Alsultan, Abdulrahman A ^a   Aboulmagd, Elsayed ^a,b   Evans, Benjamin A ^c   Amyes, Sebastian G B ^d  

^a KING FAISAL UNIVERSITY   (Saudi Arabia)

^b ALEXANDRIA UNIVERSITY   (Egypt)

^c ANGLIA RUSKIN UNIVERSITY   (United Kingdom)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAMASE; COLISTIN; IMIPENEM; MEROPENEM; TIGECYCLINE; ANTIINFECTIVE AGENT; CARBAPENEM DERIVATIVE;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CLONAL VARIATION; CLONE; DIABETIC PATIENT; GENE INSERTION SEQUENCE; HUMAN; INTENSIVE CARE; MASS SPECTROMETER; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; SAUDI ARABIA; ACINETOBACTER INFECTIONS; DIABETES MELLITUS; DRUG EFFECTS; EPIDEMIOLOGY; FEMALE; GENETIC VARIABILITY; GENETICS; GENOTYPE; MALE; MICROBIOLOGY; PULSED FIELD GEL ELECTROPHORESIS;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; CARBAPENEMS; DIABETES MELLITUS; DRUG RESISTANCE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; FEMALE; GENETIC VARIATION; GENOTYPE; HUMANS; MALE; SAUDI ARABIA;

EID: 84908324536     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.079640-0     Document Type: Article

References (41)

1. Abdalhamid, B., Hassan, H., Itbaileh, A. & Shorman, M. (2014). Characterization of carbapenem-resistant Acinetobacter baumannii clinical isolates in a tertiary care hospital in Saudi Arabia. New Microbiol 37, 65–73.
2. Agodi, A., Voulgari, E., Barchitta, M., Quattrocchi, A., Bellocchi, P., Poulou, A., Santangelo, C., Castiglione, G., Giaquinta, L. & other authors (2014). Spread of a carbapenem- and colistin-resistant Acinetobacter baumannii ST2 clonal strain causing outbreaks in two Sicilian hospitals. J Hosp Infect 86, 260–266.
3. Al-Agamy, M. H., Khalaf, N. G., Tawfick, M. M., Shibl, A. M. & El Kholy, A. (2014). Molecular characterization of carbapenem-insensitive Acinetobacter baumannii in Egypt. Int J Infect Dis 22, 49–54.
4. Al-Sweih, N. A., Al-Hubail, M. & Rotimi, V. O. (2012). Three distinct clones of carbapenem-resistant Acinetobacter baumannii with high diversity of carbapenemases isolated from patients in two hospitals in Kuwait. J Infect Public Health 5, 102–108.
5. Alsultan, A. A., Evans, B. A., Elsayed, E. A., Al-Thawadi, S. I., Al- Taher, A. Y., Amyes, S. G. B., Al-Dughaym, A. M. & Hamouda, A. (2013). High frequency of carbapenem-resistant Acinetobacter baumannii in patients with diabetes mellitus in Saudi Arabia. J Med Microbiol 62, 885–888.
6. Aly, M., Tayeb, H. T., Al Johani, S. M., Alyamani, E. J., Aldughaishem, F., Alabdulkarim, I. & Balkhy, H. H. (2014). Genetic diversity of OXA- 51-like genes among multidrug-resistant Acinetobacter baumannii in Riyadh, Saudi Arabia. Eur J Clin Microbiol Infect Dis 33, 1223–1228.
7. Ambler, R. P. (1980). The structure of b-lactamases. Philos Trans R Soc Lond B Biol Sci 289, 321–331.
8. Baadani, A. M., Thawadi, S. I., El-Khizzi, N. A. & Omrani, A. S. (2013). Prevalence of colistin and tigecycline resistance in Acinetobacter baumannii clinical isolates from 2 hospitals in Riyadh Region over a 2-year period. Saudi Med J 34, 248–253.
9. Bahador, A., Taheri, M., Pourakbari, B., Hashemizadeh, Z., Rostami, H., Mansoori, N. & Raoofian, R. (2013). Emergence of rifampicin, tigecycline, and colistin-resistant Acinetobacter baumannii in Iran; spreading of MDR strains of novel International Clone variants. Microb Drug Resist 19, 397–406.
10. Bassetti, M., Ginocchio, F., Mikulska, M., Taramasso, L. & Giacobbe, D. R. (2011). Will new antimicrobials overcome resistance among Gram-negatives? Expert Rev Anti Infect Ther 9, 909–922.
11. Brown, S. & Amyes, S. (2006). OXA (b)-lactamases in Acinetobacter: the story so far. J Antimicrob Chemother 57, 1–3.
12. CLSI (2012). Performance Standards for Antimicrobial Susceptibility Testing. Approved Standard, 22nd Informational Supplement M100- S22. Wayne, PA: Clinical and Laboratory Standards Institute.
13. Coelho, J. M., Turton, J. F., Kaufmann, M. E., Glover, J., Woodford, N., Warner, M., Palepou, M. F., Pike, R., Pitt, T. L. & other authors (2006). Occurrence of carbapenem-resistant Acinetobacter baumannii clones at multiple hospitals in London and Southeast England. J Clin Microbiol 44, 3623–3627.
14. Corvec, S., Caroff, N., Espaze, E., Giraudeau, C., Drugeon, H. & Reynaud, A. (2003). AmpC cephalosporinase hyperproduction in Acinetobacter baumannii clinical strains. J Antimicrob Chemother 52, 629–635.
15. Dijkshoorn, L., Aucken, H., Gerner-Smidt, P., Janssen, P., Kaufmann, M. E., Garaizar, J., Ursing, J. & Pitt, T. L. (1996). Comparison of outbreak and nonoutbreak Acinetobacter baumannii strains by genotypic and phenotypic methods. J Clin Microbiol 34, 1519–1525.
16. Ellington, M. J., Kistler, J., Livermore, D. M. & Woodford, N. (2007). Multiplex PCR for rapid detection of genes encoding acquired metallo-beta-lactamases. J Antimicrob Chemother 59, 321–322.
17. Héritier, C., Poirel, L. & Nordmann, P. (2006). Cephalosporinase overexpression resulting from insertion of ISAba1 in Acinetobacter baumannii. Clin Microbiol Infect 12, 123–130.
18. Karunasagar, A., Maiti, B., Shekar, M., Shenoy M S. & Karunasagar, I. (2011). Prevalence of OXA-type carbapenemase genes and genetic heterogeneity in clinical isolates of Acinetobacter spp. from Mangalore, India. Microbiol Immunol 55, 239–246.
19. Lambiase, A., Piazza, O., Rossano, F., Del Pezzo, M., Tufano, R. & Catania, M. R. (2012). Persistence of carbapenem-resistant Acinetobacter baumannii strains in an Italian intensive care unit during a forty-six month study period. New Microbiol 35, 199–206.
20. Lee, K., Yong, D., Jeong, S. H. & Chong, Y. (2011). Multidrugresistant Acinetobacter spp.: increasingly problematic nosocomial pathogens. Yonsei Med J 52, 879–891.
21. Lu, P. L., Doumith, M., Livermore, D. M., Chen, T. P. & Woodford, N. (2009). Diversity of carbapenem resistance mechanisms in Acinetobacter baumannii from a Taiwan hospital: spread of plasmid- borne OXA-72 carbapenemase. J Antimicrob Chemother 63, 641–647.
22. Manikal, V. M., Landman, D., Saurina, G., Oydna, E., Lal, H. & Quale, J. (2000). Endemic carbapenem-resistant Acinetobacter species in Brooklyn, New York: citywide prevalence, interinstitutional spread, and relation to antibiotic usage. Clin Infect Dis 31, 101–106.
23. Maragakis, L. L. & Perl, T. M. (2008). Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options. Clin Infect Dis 46, 1254–1263.
24. Miranda, G., Kelly, C., Solorzano, F., Leanos, B., Coria, R. & Patterson, J. E. (1996). Use of pulsed-field gel electrophoresis typing to study an outbreak of infection due to Serratia marcescens in a neonatal intensive care unit. J Clin Microbiol 34, 3138–3141.
25. Mohajeri, P., Farahani, A., Feizabadi, M. M., Ketabi, H., Abiri, R. & Najafi, F. (2013). Antimicrobial susceptibility profiling and genomic diversity of Acinetobacter baumannii isolates: A study in western Iran. Iran J Microbiol 5, 195–202.
26. Oteo, J., García-Estébanez, C., Migueláñez, S., Campos, J., Martí, S., Vila, J., Domínguez, M. A., Docobo, F., Larrosa, N. & other authors (2007). Genotypic diversity of imipenem resistant isolates of Acinetobacter baumannii in Spain. J Infect 55, 260–266.
27. Papp-Wallace, K. M., Endimiani, A., Taracila, M. A. & Bonomo, R. A. (2011). Carbapenems: past, present, and future. Antimicrob Agents Chemother 55, 4943–4960.
28. Paton, R., Miles, R. S., Hood, J., Amyes, S. G. B., Miles, R. S. & Amyes, S. G. (1993). ARI 1: b-lactamase-mediated imipenem resistance in Acinetobacter baumannii. Int J Antimicrob Agents 2, 81–87.
29. Peleg, A. Y., Seifert, H. & Paterson, D. L. (2008). Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 21, 538–582.
30. Poirel, L. & Nordmann, P. (2006a). Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin Microbiol Infect 12, 826–836.
31. Poirel, L. & Nordmann, P. (2006b). Genetic structures at the origin of acquisition and expression of the carbapenem-hydrolyzing oxacillinase gene blaOXA-58 in Acinetobacter baumannii. Antimicrob Agents Chemother 50, 1442–1448.
32. Poirel, L., Potron, A. & Nordmann, P. (2012). OXA-48-like carbapenemases: the phantom menace. J Antimicrob Chemother 67, 1597–1606.
33. Qi, C., Malczynski, M., Parker, M. & Scheetz, M. H. (2008). Characterization of genetic diversity of carbapenem-resistant Acinetobacter baumannii clinical strains collected from 2004 to 2007. J Clin Microbiol 46, 1106–1109.
34. Shahcheraghi, F., Abbasalipour, M., Feizabadi, M., Ebrahimipour, G. & Akbari, N. (2011). Isolation and genetic characterization of metallob- lactamase and carbapenamase producing strains of Acinetobacter baumannii from patients at Tehran hospitals. Iran J Microbiol 3, 68–74.
35. Souli, M., Galani, I. & Giamarellou, H. (2008). Emergence of extensively drug-resistant and pandrug-resistant Gram-negative bacilli in Europe. Euro Surveill 13, 19045.http://www.eurosurveillance.org/ViewArticle. aspx?ArticleId=19045
36. Turton, J. F., Ward, M. E., Woodford, N., Kaufmann, M. E., Pike, R., Livermore, D. M. & Pitt, T. L. (2006a). The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii. FEMS Microbiol Lett 258, 72–77.
37. Turton, J. F., Woodford, N., Glover, J., Yarde, S., Kaufmann, M. E. & Pitt, T. L. (2006b). Identification of Acinetobacter baumannii by detection of the blaOXA-51-like carbapenemase gene intrinsic to this species. J Clin Microbiol 44, 2974–2976.
38. Villalón, P., Valdezate, S., Medina-Pascual, M. J., Carrasco, G., Vindel, A. & Saez-Nieto, J. A. (2013). Epidemiology of the Acinetobacter-derived cephalosporinase, carbapenem-hydrolysing oxacillinase and metallo-β-lactamase genes, and of common insertion sequences, in epidemic clones of Acinetobacter baumannii from Spain. J Antimicrob Chemother 68, 550–553.
39. Walther-Rasmussen, J. & Høiby, N. (2006). OXA-type carbapenemases. J Antimicrob Chemother 57, 373–383.
40. Wang, X., Qiao, F., Yu, R., Gao, Y. & Zong, Z. (2013). Clonal diversity of Acinetobacter baumannii clinical isolates revealed by a snapshot study. BMC Microbiol 13, 234.
41. Woodford, N., Ellington, M. J., Coelho, J. M., Turton, J. F., Ward, M. E., Brown, S., Amyes, S. G. & Livermore, D. M. (2006). Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int J Antimicrob Agents 27, 351–353.